FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

734464004: Cilastatin sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3506951018 Cilastatin sodium (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3506952013 Cilastatin sodium en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilastatin sodium Is a Cilastatin false Inferred relationship Existential restriction modifier
Cilastatin sodium Has disposition Peptide hydrolase inhibitor true Inferred relationship Existential restriction modifier
Cilastatin sodium Is a Substance with peptide hydrolase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Cilastatin sodium Is modification of Cilastatin true Inferred relationship Existential restriction modifier
Cilastatin sodium Is a Organic sulfide compound true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has precise active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier 2
Product containing precisely cilastatin (as cilastatin sodium) 250 milligram and imipenem anhydrous (as imipenem) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier 2
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has precise active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier 2
Generic Recarbrio 500mg/500mg/250mg powder for solution for infusion vials Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Recarbrio 500mg/500mg/250mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 25 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Recarbrio 500mg/500mg/250mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Generic Recarbrio 500mg/500mg/250mg powder for solution for infusion vials 25 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials 1 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials 5 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Hospira UK Ltd) 5 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Hospira UK Ltd) 1 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials 10 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) 10 vial Has specific active ingredient True Cilastatin sodium Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start